Ophthalmic services for children EDITOR,-It was with interest that I read the report of the joint working party produced by the Royal College of Ophthalmologists and the British Paediatric Association, December 1994.1 This is an excellent report, clearly presented and easily readable. The report makes many very worthy recommendations, but a degree of public debate will be required to bring these recommendations into being. I would like to highlight a few points:
(1) Do paediatric senior house officers (or obstetric senior house officers, if there are no resident paediatricians) actually receive at least one tutorial near the beginning of their 6 month posts by an ophthalmologist in most hospitals? (Ch 1.5). If not, in the same way that many units provide teaching for casualty officers, should we not do likewise for the paediatricians? This teaching could be provided by a registrar or senior registrar.
(2) With respect to screening for retinopathy of prematurity (Ch 4.1.1), the report states 'a designated ophthalmologist, suitably trained, should provide this service'. In many hospitals no one provides this service, and in some it is delegated to the registrar. The question 'Is this acceptable?' should at least be asked.
(3) Chapter 7, paragraph 4, of the report advises that a multidisciplinary visual disability team We have recently developed a rabbit model of retinal artery occlusion using human atherosclerotic material (Ciulla et al, Curr Eye Res, in press). Fresh human atherosclerotic plaque was harvested from atherosclerotic human aorta by mechanical removal and suspension in normal saline. The suspension was agitated vigorously to produce small particles, which were separated into various sizes by filtration through mesh filters. The common carotid artery of the anaesthetised rabbit was isolated by neck dissection, cannulated, and injected with suspensions ofhuman atherosclerotic plaque. Ophthalmoscopy and fluorescein angiography confirmed that plaque particles of less than 105 p.m reliably produced branch retinal artery occlusion, while larger plaque particles of less than 149 p.m reliably produced central retinal artery occlusion. Four rabbits with visible branch retinal artery emboli underwent attempted laser photodisruption with argon green laser in a fashion similar to that described by Dutton and Craig. Multiple spots of argon green laser (4-10 spots at 0-1-0-2 W, 50 p.m spot size, and 0-1 second exposure) were applied to the embolus. The procedure was unsuccessful in three rabbits. In a fourth rabbit, the visible embolus was fragmented by the laser energy, and the fragments passed distally.
The treatment was also attempted in a 69-year-old woman who presented within 1 hour after experiencing acute loss of vision in the left eye. She was noted to have a refractile intra-arteriole embolus at the optic disc. Despite ocular massage and anterior chamber paracentesis, visual acuity remained at light perception. Laser photodisruption, using the settings noted above, was attempted. Arterial circulation appeared to improve, but the embolus remained in place. One week later, visual acuity remained at light perception and the retinal vessels were reperfused, with the embolus located distally within the inferotemporal arteriole.
In (1) The melting point of cholesterol is such that the cholesterol of synchisis scintillans in the anterior chamber of an aphakic eye disappears when a hairdryer is played upon the closed eyelid.1 (2) Cholesterol, like xanthophyll, is yellow and thus will absorb blue light with conversion to heat. (We did not anticipate that the green component or the argon laser light would heat the yellow embolus to the same degree and for that reason did not filter out the blue light.) (3) Warming of the embolus requires a continuous application of energy until melting takes place. Intermittent short laser applications would not be expected to achieve the same effect. In our patient (in whom established treatment methods had failed) we applied continuous argon blue-green laser light with the minimum energy and spot size available. After a few seconds the embolus vanished and reappeared at the next retinal arterial junction. A repeat identical application resulted in the embolus disappearing altogether. Unfortunately, our treatment did not restore vision but we anticipate that it would do so in any similar patient with a very short history of loss of vision.
Ciulla and colleagues did not apply the above rationale and the lack of therapeutic efficacy from short duration multiple applications of argon green only light is perhaps not surprising.
The concept of using a short pulsed laser is an interesting alternative, but vessel rupture with the potential for intraocular bleeding if such a rupture takes place upstream of the embolus is a theoretical hazard.
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Requests The International Symposium on Fluorescence Angiography will be held in St-Gall, Switzerland on 8-12 September 1996. This will immediately follow the Gonin meeting in Bern, Switzerland, which will take place on 1-6 September 1996.
